Is Nrf2-ARE a potential target in NAFLD mitigation?

[1]  G. Michalopoulos,et al.  Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice. , 2018, American journal of physiology. Endocrinology and metabolism.

[2]  Masayuki Yamamoto,et al.  The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. , 2018, Physiological reviews.

[3]  S. Xia,et al.  Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation. , 2018, Food & function.

[4]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[5]  Hua Fan,et al.  Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[6]  L. Videla,et al.  Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation. , 2017, Molecular nutrition & food research.

[7]  C. Chen,et al.  Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway , 2017, Evidence-based complementary and alternative medicine : eCAM.

[8]  Pingping Shen,et al.  Apigenin, a modulator of PPAR&ggr;, attenuates HFD‐induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation , 2017, Biochemical pharmacology.

[9]  L. Videla,et al.  Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation. , 2017, Food & function.

[10]  Shuichi Kaneko,et al.  Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice , 2017, Diabetes.

[11]  Hyung Gyun Kim,et al.  Saponins from the roots of Platycodon grandiflorum ameliorate high fat diet-induced non-alcoholic steatohepatitis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  G. Le,et al.  Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet , 2016, Nutrients.

[13]  M. Andersen,et al.  An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. , 2016, Free radical biology & medicine.

[14]  B. Cha,et al.  Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. , 2016, Free radical biology & medicine.

[15]  S. Wild,et al.  Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. , 2016, Journal of hepatology.

[16]  Q. Wen,et al.  Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. , 2016, Molecular medicine reports.

[17]  J. Tomlinson,et al.  Non-alcoholic fatty liver disease and diabetes , 2016, Metabolism: clinical and experimental.

[18]  Shang-Rong Xu,et al.  NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  T. Ikeda,et al.  6‐Methylsulfinylhexyl isothiocyanate prevents high‐fat diet‐induced fatty liver but fails to attenuate hepatic iron accumulation in mice , 2016, Clinical and experimental pharmacology & physiology.

[20]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[21]  S. M. Nambiar,et al.  Nuclear Factor Erythroid 2–Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[22]  Yong Huang,et al.  S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway , 2016, Oxidative medicine and cellular longevity.

[23]  Zhihui Feng,et al.  Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system. , 2016, Molecular nutrition & food research.

[24]  Y. Bao,et al.  Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK , 2016, Endocrine.

[25]  Wei-Jia Kong,et al.  Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway , 2016, Phytotherapy research : PTR.

[26]  M. Vawter,et al.  Increased Energy Expenditure, Ucp1 Expression, and Resistance to Diet-induced Obesity in Mice Lacking Nuclear Factor-Erythroid-2-related Transcription Factor-2 (Nrf2)* , 2016, The Journal of Biological Chemistry.

[27]  G. Ioannou.  The Role of Cholesterol in the Pathogenesis of NASH , 2016, Trends in Endocrinology & Metabolism.

[28]  C. Trautwein,et al.  Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development. , 2016, Free radical biology & medicine.

[29]  Donna D. Zhang,et al.  p62 links autophagy and Nrf2 signaling. , 2015, Free radical biology & medicine.

[30]  Jeong Su Park,et al.  Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. , 2015, Biochemical and biophysical research communications.

[31]  P. Deloron,et al.  Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria , 2015, Malaria Journal.

[32]  Sufang Wang,et al.  Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults , 2015, Nutrients.

[33]  R. Reiter,et al.  Diabetes and Alzheimer Disease, Two Overlapping Pathologies with the Same Background: Oxidative Stress , 2015, Oxidative medicine and cellular longevity.

[34]  S. Manti,et al.  Oxidative Stress in Obesity: A Critical Component in Human Diseases , 2014, International journal of molecular sciences.

[35]  S. Werner,et al.  Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  U. Förstermann,et al.  Vascular oxidative stress, nitric oxide and atherosclerosis. , 2014, Atherosclerosis.

[37]  X. Hang,et al.  Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. , 2014, European Journal of Pharmacology.

[38]  S. Sarin,et al.  World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2014, Journal of clinical gastroenterology.

[39]  F. J. Romero,et al.  Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy , 2014, Oxidative medicine and cellular longevity.

[40]  W. Nseir,et al.  Role of diet and lifestyle changes in nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[41]  J. Hayes,et al.  Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance , 2014, Molecular and Cellular Biology.

[42]  M. Mollica,et al.  c9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway[S] , 2014, Journal of Lipid Research.

[43]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[44]  Ying Zhang,et al.  Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. , 2014, The Biochemical journal.

[45]  J. McMurray,et al.  Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. , 2013, The New England journal of medicine.

[46]  Yanhua Zhang,et al.  Nrf2 deletion causes “benign” simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet , 2013, Lipids in Health and Disease.

[47]  H. Yao,et al.  Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. , 2013, Arquivos brasileiros de endocrinologia e metabologia.

[48]  F. Zhai,et al.  Programme and policy options for preventing obesity in China , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[49]  I. Cho,et al.  Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. , 2013, Toxicology and applied pharmacology.

[50]  Masayuki Yamamoto,et al.  Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding. , 2013, Free radical biology & medicine.

[51]  Jian-Gao Fan,et al.  Epidemiology of alcoholic and nonalcoholic fatty liver disease in China , 2013, Journal of gastroenterology and hepatology.

[52]  M. Yamada,et al.  Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model , 2013, Molecular Pharmacology.

[53]  P. Gill,et al.  Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. , 2013, Journal of hepatology.

[54]  L. Beilin,et al.  The Western Dietary Pattern Is Prospectively Associated With Nonalcoholic Fatty Liver Disease in Adolescence , 2013, The American Journal of Gastroenterology.

[55]  M. Lazo,et al.  Racial Differences in Nonalcoholic Fatty Liver Disease in the U.S. Population , 2013, Obesity.

[56]  T. Moliné,et al.  Oxidative stress and cancer: An overview , 2013, Ageing Research Reviews.

[57]  Ian M Adcock,et al.  Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[58]  T. Ikeda,et al.  Dysregulated expression of fatty acid oxidation enzymes and iron‐regulatory genes in livers of Nrf2‐null mice , 2012, Journal of gastroenterology and hepatology.

[59]  Jie Liu,et al.  Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. , 2012, Toxicology and applied pharmacology.

[60]  Virginia Nguyen,et al.  Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production* , 2012, The Journal of Biological Chemistry.

[61]  M. Abraham,et al.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis , 2012, Hepatology.

[62]  Y. Soejima,et al.  Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2012, World journal of gastroenterology.

[63]  G. Musso,et al.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials , 2012, Diabetologia.

[64]  J. Heimbach,et al.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.

[65]  A. Papavassiliou,et al.  Nrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice , 2011, Diabetes.

[66]  Won Dong Kim,et al.  Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. , 2011, Antioxidants & redox signaling.

[67]  B. Ryffel,et al.  Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria , 2011, PLoS pathogens.

[68]  P. López-Jaramillo,et al.  Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. , 2011, Preventive medicine.

[69]  Jiansheng Huang,et al.  Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[70]  Masayuki Yamamoto,et al.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver , 2010, Journal of proteomics.

[71]  C. Klaassen,et al.  Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. , 2010, Toxicology and applied pharmacology.

[72]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[73]  H. Tilg.  The Role of Cytokines in Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[74]  I. Hyodo,et al.  Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[75]  J. Hayes,et al.  Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. , 2010, Free radical biology & medicine.

[76]  S. Caldwell,et al.  Epidemiology and natural history of non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[77]  M. Sporn,et al.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. , 2009, Carcinogenesis.

[78]  R. Xu,et al.  Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease , 2008, Hepatology.

[79]  C. Klaassen,et al.  NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet , 2008, Journal of Pharmacology and Experimental Therapeutics.

[80]  O. Nóbrega,et al.  Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults , 2007, Sao Paulo medical journal = Revista paulista de medicina.

[81]  R. Brigelius-Flohé,et al.  The GI-GPx Gene Is a Target for Nrf2 , 2005, Molecular and Cellular Biology.

[82]  M. Kelley,et al.  Safety and Efficacy of Weekly Oral Oltipraz in Chronic Smokers , 2005, Cancer Epidemiology Biomarkers & Prevention.

[83]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[84]  A. Diehl,et al.  Cytokines and the pathogenesis of non-alcoholic steatohepatitis , 2005, Gut.

[85]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[86]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[87]  H. Akaza,et al.  Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis , 2004, Cancer Research.

[88]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[89]  D. Kleiner,et al.  Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. , 2004, Human pathology.

[90]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[91]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[92]  F. Schaffner,et al.  Fatty liver hepatitis and cirrhosis in obese patients. , 1979, The American journal of medicine.

[93]  C. Palmeira,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free radical biology & medicine.

[94]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.